Tuesday, October 28, 2008

Talyst ranks in fastest-growing private companies 4 years running 10/28/08

Bellevue, Wash., Oct. 28, 2008 — For the fourth consecutive year, Talyst has been named to the Puget Sound Business Journal’s “Washington 100 Fastest Growing Private Companies” list.

The company ranked six on the list, up from 10 last year. The latest ranking reflects 363.8 percent revenue growth from 2005 to 2007.

Talyst produces innovative pharmacy systems that enhance efficiency and patient safety. In acute-care environments, the company’s AutoPharm® software platform and AutoPack®, AutoLabel™ and AutoCarousel™ equipment work together to distribute and track medication inventory. In long-term care and correctional systems, Talyst InSite™ systems provide efficiencies and safety advantages of remote dispensing.

“We are honored at this repeat ranking, and we quickly share credit for it with our forward-looking customers, partners and employees.” said Carla Corkern, chief executive officer. “More than ever, health care facilities need the safety, value and efficiency advantages we are delivering.”

In other fast-growth honors, Talyst this year was named for the second time to the Inc. magazine “Inc. 500” list of fastest-growing U.S. private companies. Last month, the company was ranked number two on the Deloitte “Fast 50” Technology Companies in Washington state.

About Talyst
Talyst enables the intelligent pharmacy. The company provides automated systems to hospitals, long-term care and correctional systems, to improve accuracy and patient safety, while reducing costs and increasing productivity. Talyst equipment and software are used to package, barcode, store and track medication inventories. The company has more than 300 hospital and integrated healthcare system customers.

For more information, see Talyst.com or call 877-4-Talyst (877-482-5978).

Talyst, InSite and Engineering the Intelligent Pharmacy are trademarks of Talyst Inc. Other trade names are the property of their respective owners.


Bookmark and Share


No comments:

Post a Comment